CDA | Evidence Driven
CDA | Evidence Driven

Somatropin for Idiopathic Short Stature

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1670-000
Effective finish date:

Question

  1. What are the evidence-based guidelines regarding the use of growth hormone therapy for children with idiopathic short stature?

Key Message

We identified 1 evidence-based guideline about the use of growth hormone therapy for children with idiopathic short stature.

Files

Somatropin for Idiopathic Short Stature View PDF
Last Updated : June 27, 2023